Amneal Pharmaceuticals (AMRX) Prepaid Assets (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded quarterly Prepaid Assets of $103.1 million in Q1 2026, up 4.77% quarter-over-quarter from $98.4 million in Q4 2025, and up 16.46% on a YoY basis from $88.5 million in Q1 2025.
Amneal Pharmaceuticals (AMRX) Prepaid Assets (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Prepaid Assets history runs 10 years deep, the most recent figure standing at $103.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 16.46% year-over-year to $103.1 million; the TTM figure through Mar 2026 stood at $103.1 million (up 16.46% YoY), while the FY2025 annual figure was $98.4 million, up 21.9% from the prior year.
- Prepaid Assets was $103.1 million for Q1 2026 at Amneal Pharmaceuticals, up from $98.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $232.2 million in Q2 2022 to a low of $80.7 million in Q4 2024.
- Historically, Prepaid Assets has averaged $103.1 million across 5 years, with a median of $88.5 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 123.71% in 2022, then slumped 64.79% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $103.6 million in 2022, then fell by 20.16% to $82.7 million in 2023, then retreated by 2.38% to $80.7 million in 2024, then advanced by 21.9% to $98.4 million in 2025, then climbed by 4.77% to $103.1 million in 2026.
- The last three Prepaid Assets figures came in at $103.1 million (Q1 2026), $98.4 million (Q4 2025), and $101.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Amneal Pharmaceuticals | 4.66 Bn | 4.65 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.09 Mn |
| Dec 31, 2025 | 98.40 Mn |
| Sep 30, 2025 | 101.51 Mn |
| Jun 30, 2025 | 85.30 Mn |
| Mar 31, 2025 | 88.52 Mn |
| Dec 31, 2024 | 80.72 Mn |
| Sep 30, 2024 | 81.96 Mn |
| Jun 30, 2024 | 81.60 Mn |
| Mar 31, 2024 | 87.30 Mn |
| Dec 31, 2023 | 82.69 Mn |
| Sep 30, 2023 | 91.44 Mn |
| Jun 30, 2023 | 81.76 Mn |
| Mar 31, 2023 | 81.42 Mn |
| Dec 31, 2022 | 103.57 Mn |
| Sep 30, 2022 | 149.65 Mn |
| Jun 30, 2022 | 232.20 Mn |
| Mar 31, 2022 | 121.41 Mn |
| Dec 31, 2021 | 110.22 Mn |
| Sep 30, 2021 | 110.21 Mn |
| Jun 30, 2021 | 103.80 Mn |